CanadaBis Capital Inc. (CANB.V)

CAD 0.09

(-5.56%)

Revenue Summary of CanadaBis Capital Inc.

  • CanadaBis Capital Inc.'s latest annual revenue in 2023 was 22.22 Million CAD , up 90.44% from previous year.
  • CanadaBis Capital Inc.'s latest quarterly revenue in 2024 Q3 was 3.96 Million CAD , down -7.86% from previous quarter.
  • CanadaBis Capital Inc. reported a annual revenue of 11.66 Million CAD in annual revenue 2022, up 69.95% from previous year.
  • CanadaBis Capital Inc. reported a annual revenue of 6.86 Million CAD in annual revenue 2021, up 55.04% from previous year.
  • CanadaBis Capital Inc. reported a quarterly revenue of 5.74 Million CAD for 2024 Q1, up 19.52% from previous quarter.
  • CanadaBis Capital Inc. reported a quarterly revenue of 4.3 Million CAD for 2024 Q2, down -24.98% from previous quarter.

Annual Revenue Chart of CanadaBis Capital Inc. (2023 - 2017)

Historical Annual Revenue of CanadaBis Capital Inc. (2023 - 2017)

Year Revenue Revenue Growth
2023 22.22 Million CAD 90.44%
2022 11.66 Million CAD 69.95%
2021 6.86 Million CAD 55.04%
2020 4.42 Million CAD 0.0%
2019 - CAD 0.0%
2018 - CAD 0.0%
2017 - CAD 0.0%

Peer Revenue Comparison of CanadaBis Capital Inc.

Name Revenue Revenue Difference
Aequus Pharmaceuticals Inc. 254.89 Thousand CAD -8618.243%
Decibel Cannabis Company Inc. 115.95 Million CAD 80.836%
Delivra Health Brands Inc. 12.37 Million CAD -79.532%
Entourage Health Corp. 40.71 Million CAD 45.417%
Lifeist Wellness Inc. 21.65 Million CAD -2.598%
Cannara Biotech Inc. 57.26 Million CAD 61.19%
Medicure Inc. 21.69 Million CAD -2.436%
PharmaCielo Ltd. 1.54 Million CAD -1341.379%
Rubicon Organics Inc. 40.11 Million CAD 44.605%
BioSyent Inc. 31.59 Million CAD 29.654%
Voyageur Pharmaceuticals Ltd. - CAD -Infinity%